Annual Retained Earnings
-$825.68 M
-$259.34 M-45.79%
31 March 2024
Summary:
Immunovant annual retained earnings is currently -$825.68 million, with the most recent change of -$259.34 million (-45.79%) on 31 March 2024. During the last 3 years, it has fallen by -$627.03 million (-315.63%). IMVT annual retained earnings is now -206420650.00% below its all-time high of -$400.00, reached on 31 December 2018.IMVT Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$1.02 B
-$109.12 M-11.95%
30 September 2024
Summary:
Immunovant quarterly retained earnings is currently -$1.02 billion, with the most recent change of -$109.12 million (-11.95%) on 30 September 2024. Over the past year, it has dropped by -$323.01 million (-46.21%). IMVT quarterly retained earnings is now -333091.85% below its all-time high of $306.90 thousand, reached on 30 September 2019.IMVT Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMVT Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.8% | -46.2% |
| 3 y3 years | -315.6% | -283.0% |
| 5 y5 years | -10000.0% | -10000.0% |
IMVT Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -315.6% | at low | -283.0% | at low |
| 5 y | 5 years | <-9999.0% | at low | <-9999.0% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Immunovant Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.02 B(+12.0%) |
| June 2024 | - | -$912.83 M(+10.6%) |
| Mar 2024 | -$825.68 M(+45.8%) | -$825.68 M(+10.0%) |
| Dec 2023 | - | -$750.36 M(+7.4%) |
| Sept 2023 | - | -$698.95 M(+9.2%) |
| June 2023 | - | -$640.28 M(+13.1%) |
| Mar 2023 | -$566.35 M(+59.4%) | -$566.35 M(+11.7%) |
| Dec 2022 | - | -$506.92 M(+14.3%) |
| Sept 2022 | - | -$443.69 M(+12.1%) |
| June 2022 | - | -$395.76 M(+11.4%) |
| Mar 2022 | -$355.39 M | -$355.39 M(+15.3%) |
| Dec 2021 | - | -$308.22 M(+15.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | -$266.83 M(+16.5%) |
| June 2021 | - | -$229.13 M(+15.3%) |
| Mar 2021 | -$198.66 M(+117.8%) | -$198.66 M(+16.5%) |
| Dec 2020 | - | -$170.50 M(+22.9%) |
| Sept 2020 | - | -$138.72 M(+17.6%) |
| June 2020 | - | -$117.93 M(+29.3%) |
| Mar 2020 | -$91.23 M(>+9900.0%) | -$91.23 M(+29.1%) |
| Dec 2019 | - | -$70.67 M(<-9900.0%) |
| Sept 2019 | - | $306.90 K(+68.7%) |
| June 2019 | - | $181.90 K(<-9900.0%) |
| Mar 2019 | - | -$900.00 |
| Dec 2018 | -$400.00 | - |
FAQ
- What is Immunovant annual retained earnings?
- What is the all time high annual retained earnings for Immunovant?
- What is Immunovant annual retained earnings year-on-year change?
- What is Immunovant quarterly retained earnings?
- What is the all time high quarterly retained earnings for Immunovant?
- What is Immunovant quarterly retained earnings year-on-year change?
What is Immunovant annual retained earnings?
The current annual retained earnings of IMVT is -$825.68 M
What is the all time high annual retained earnings for Immunovant?
Immunovant all-time high annual retained earnings is -$400.00
What is Immunovant annual retained earnings year-on-year change?
Over the past year, IMVT annual retained earnings has changed by -$259.34 M (-45.79%)
What is Immunovant quarterly retained earnings?
The current quarterly retained earnings of IMVT is -$1.02 B
What is the all time high quarterly retained earnings for Immunovant?
Immunovant all-time high quarterly retained earnings is $306.90 K
What is Immunovant quarterly retained earnings year-on-year change?
Over the past year, IMVT quarterly retained earnings has changed by -$323.01 M (-46.21%)